CHARACTERIZATION OF ADAPTIVE IMMUNE RESPONSE TO VACCINATION OR INFECTION USING IMMUNE REPERTOIRE SEQUENCING
Patent №
US 11,066,705
Granted
2021-07-20
Filed 2017
Owner
ADAPTIVE BIOTECHNOLOGIES CORP.
+2 more
Lab
—
AI components
1
hardware
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
15529943
Methods of monitoring and measuring dynamic adaptive immune cell responses are provided. High-throughput sequencing of T cell receptor and immunoglobulin loci is used to characterize the breadth of an effector cell response to a stimulus, such as a vaccine or infection. Unique responding effector cell clones and abundance thereof can be determined. Additionally, methods for determining the contribution of responding effector cells to the immunological memory compartment are provided.
AI classification
Ownership
ADAPTIVE BIOTECHNOLOGIES CORP.
assignment · 439730235
FRED HUTCHINSON CANCER RESEARCH CENTER
assignment · 439730374
FRED HUTCHINSON CANCER CENTER
merger · 609820053
Assignors
DEWITT, WILLIAM SUMNER, III, EMERSON, RYAN O.
On an employer assignment, the assignors are typically the inventors.